Home/Filings/4/0001645572-18-000004
4//SEC Filing

Eyre Brik V 4

Accession 0001645572-18-000004

CIK 0000010456other

Filed

May 9, 8:00 PM ET

Accepted

May 10, 4:29 PM ET

Size

11.4 KB

Accession

0001645572-18-000004

Insider Transaction Report

Form 4
Period: 2018-05-08
Eyre Brik V
CVP, Hospital Products
Transactions
  • Sale

    Common Stock, $1 par value

    2018-05-08$69.61/sh36,359$2,530,95065,115 total
  • Exercise/Conversion

    Common Stock, $1 par value

    2018-05-08$37.38/sh+20,000$747,600101,474 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2018-05-084,4140 total
    Exercise: $37.38From: 2016-03-03Exp: 2025-03-03Common Stock, $1 par value (4,414 underlying)
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2018-05-0815,58635,828 total
    Exercise: $37.38From: 2017-03-03Exp: 2025-03-03Common Stock, $1 par value (15,586 underlying)
Footnotes (3)
  • [F1]Transaction effected pursuant to a Rule 10b5-1 trading plan entered into by Mr. Eyre with respect to certain vested stock options previously granted by Baxter International Inc. ("BII") to Mr. Eyre.
  • [F2]Transaction effected pursuant to a Rule 10b5-1 trading plan entered into by Mr. Eyre with respect to certain vested stock options and restricted stock units previously granted by BII to Mr. Eyre.
  • [F3]Price reflects weighted average sales price. Range of prices for transactions are $63.31 through $70.15. Full information regarding the number of shares sold at each separate price will be provided by the issuer upon request.

Issuer

BAXTER INTERNATIONAL INC

CIK 0000010456

Entity typeother

Related Parties

1
  • filerCIK 0001645572

Filing Metadata

Form type
4
Filed
May 9, 8:00 PM ET
Accepted
May 10, 4:29 PM ET
Size
11.4 KB